Viewing a single comment thread. View all comments

PatentSavvy t1_j7mo0tm wrote

Are you guys engaged in protecting your methods of drug discovery via patent applications? Or do you guys plan on protecting any potential candidates once their existence becomes known through the methods? Or both?

As a patent attorney, your model sounds interesting and I hope you protect your discoveries and inventions. I have been involved in patents relating to pharmaceutical design and drug development and have seen the various processes first hand. It definitely is an iterative and arduous process but it can be totally worth it in the end if you have that one successful candidate that proves therapeutically effective and obtains FDA approval.

2

ShakeNBakeGibson OP t1_j7msdaz wrote

We certainly protect and will continue to protect our development candidates using industry standard kinds of patent filings. But, as you imply, our development candidates are only a small part of the innovation that happens at Recursion. We do have multiple patents and filings on our RecursionOS, but we also look at protecting inventions in the biology and hardware spaces where we innovate. We also protect some of the key advances on our platform via trade secret. This doesn’t even take into account the massive amount of proprietary data we’ve generated.
That said, we think we can contribute a lot to open-science without giving away our advantage - see [our RxRx datasets](https://www.rxrx.ai/) and [publications](https://www.recursion.com/scientificmaterials).

3